Janus Henderson Group
EBS icon

Janus Henderson Group’s Emergent Biosolutions EBS Stock Holding History

Janus Henderson Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,359
Closed -$69.3K – 2567
2023
Q3 		$69.3K Buy
20,359
+55
+0.3% +$305 ﹤0.01% 2543
2023
Q2 		$149K Sell
20,304
-44
-0.2% -$408 ﹤0.01% 2518
2023
Q1 		$211K Sell
20,348
-47,024
-70% -$568K ﹤0.01% 2470
2022
Q4 		$796K Sell
67,372
-4,861
-7% -$75.2K ﹤0.01% 1485
2022
Q3 		$1.52M Sell
72,233
-866
-1% -$24.1K ﹤0.01% 1140
2022
Q2 		$2.27M Sell
73,099
-720,233
-91% -$24.6M ﹤0.01% 1006
2022
Q1 		$32.6M Sell
793,332
-1,029,549
-56% -$45.4M 0.02% 622
2021
Q4 		$79.2M Sell
1,822,881
-1,047,022
-36% -$47.4M 0.03% 414
2021
Q3 		$144M Sell
2,869,903
-779,066
-21% -$47.2M 0.06% 289
2021
Q2 		$230M Buy
3,648,969
+889,033
+32% +$57.1M 0.1% 212
2021
Q1 		$256M Buy
2,759,936
+1,815,872
+192% +$186M 0.12% 191
2020
Q4 		$84.6M Buy
+944,064
New +$86.6M 0.04% 406
2018
Q2 		– Sell
-4,051
Closed -$213K – 1403
2018
Q1 		$213K Buy
+4,051
New +$202K ﹤0.01% 1337

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group's EBS Position: Q4 2023 in Review

Janus Henderson Group sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 20,359 shares — an estimated $69.3K sold.

Janus Henderson Group first reported a position in EBS in Q1 2018 and held it in 13 quarters. The position peaked at $256M in Q1 2021. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Janus Henderson Group reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 20,359 Emergent Biosolutions shares in Q4 2023, an estimated $69.3K.
  • Janus Henderson Group first reported a position in Emergent Biosolutions in Q1 2018 and held it in 13 quarters.
  • Janus Henderson Group's Emergent Biosolutions position peaked at $256M in Q1 2021.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.